Doctor who found Omicron variant says symptoms are mild, media is overreacting

Chairwoman of the South African Medical Association Dr. Angelique Coetzee, one of the doctors who first identified the Omicron variant of COVID-19, says that the government and media are overreacting to an even milder strain of COVID.

Thomas Lambert

November 29, 2021


Chairwoman of the South African Medical Association and private practitioner Dr. Angelique Coetzee, one of the doctors who first identified the Omicron variant of COVID-19, says that the government and media are overreacting to an even milder strain of COVID.

“Looking at the mildness of the symptoms that we are seeing, currently there is no reason for panicking, as we don’t see severely ill patients,” explained Coetzee in an interview with Reuters.

“I also checked with the hospitals, some of the hospitals in my area, and one of the biggest hospitals that have one patient currently that’s COVID positive on a ventilator, and they don’t even know whether it’s COVID or whether it’s Delta, or whether it is Omicron related.”

“We acknowledge that it might change going forward,” Coetzee continues, “but the hype that’s been created out currently out there in the media and worldwide doesn’t correlate with the clinical picture. And it doesn’t warrant to just cut us off from any travelling and ban South Africa as if we are the variants in the whole process.”

“It should not be like that.”

Coetzee further details the discovery of the new variant, saying that she hadn’t seen a COVID patient in months until a few patients came in showing some symptoms consistent and inconsistent with the Delta variant, prompting South African doctors to administer tests.

Again, she stresses that the new symptoms she saw, including excess fatigue, are mild and adds that symptoms are so mild they can be treated at home over a few days.

Moreover, not a single patient diagnosed with the Omicron variant needed to be taken to surgery or ICUs.

Two differences between the Omicron and Deltas variant, which Coetzee notes, is that patients do not report a loss of taste nor significant drops in oxygen levels.

Despite her report, the media has fired up the fearmongering machine, again, pumping out article after article justifying the government’s imposition of travel bans and other restrictions.

Pharmaceutical companies are also preparing for their next cash grab, saying they’ll have a new vaccine ready in three to four months, as some reports suggest the Omicron is resistant to current vaccines.

So, don’t worry. The government will still compel you to get jabbed for an even less-lethal variant of an already mild virus.

Support our work

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

Dozens of MSM outlets have once again propped up anti-Poilievre sentiment, this time by sourcing a long-time Liberal Party booster.

Mike Campbell

March 28, 2024

Trending News

The number of CRA employees terminated for wrongfully claiming CERB at the height of the lockdowns has risen to 232.

TCS Wire

March 27, 2024

Trending News

Following the recently revealed cancer diagnosis of Kate Middleton (just 42), many have speculated that there seems to be an increasing number of young, otherwise healthy people being diagnosed with cancer and dying since the vaccine rollout. And studies say they’re not wrong.

TCS Wire

March 25, 2024

Trending News

Having faced years of persecution for her tweets denouncing the vaccine mandate and lockdowns, Dr. Kulvinder Kaur Gill has asked Elon Musk for assistance in handling her most recent legal bill. And Musk has responded.

Keean Bexte

March 22, 2024

Trending News

Nurses gassed over vaccine mandate are reinstated after getting fired for “misconduct.”

Mike Campbell

March 5, 2024

Trending News

Australian Supreme Court Judge rules COVID vaccine mandate was unlawful for police and ambulance workers.

Alexa Posa

February 27, 2024

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.